Incyte Corporation (INCY) has recently garnered attention from Marc Frahm, an analyst at TD Cowen. In a report released yesterday, Frahm reaffirmed his "Buy" rating on the biopharmaceutical company, setting a price target of $88.00. This upbeat outlook comes as Incyte's shares closed...
DHS Launches Polygraph Tests toCombat Leaks of Immigration Raid Details
The Department of Homeland Security (DHS) has recently begun administering polygraph tests...
Edinburgh's education system faces a significant setback as plans to cut over £8 million from school funding have elicited strong criticism. Described as "absolutely...
Aberdeen, renowned as Europe's Oil and Gas capital, faces a stark reality of economic disparity and increasing poverty during the prevailing cost-of-living crisis. An...
In a bid to rectify Southampton's "broken housing market," the city's new council leader, Cllr Lorna Fielker, is committed to collaborating with diverse partners...